Related stories
Nxera Pharma to Receive $100 Million Upfront and Up to $1.37 Billion in Milestones
Nxera Pharma is set to receive $100 million upfront, up to $1.37 billion in milestone payments, plus royalties.
M impact | EQUITY | Nov 04, 2026, 08:43 AM UTC
U.S. Refinery Stocks Rise Amid Energy Crisis
U.S. refinery shares rose during the energy crisis; the report provides no magnitude or specific catalyst.
M impact | EQUITY | Nov 04, 2026, 08:43 AM UTC
Indian Metals & Ferro Alloys Reports Q2 Consolidated Net Profit of INR 1,477 Million
M impact | EQUITY | Nov 04, 2026, 08:43 AM UTC
Lunit to Issue Private Convertible Bonds
Lunit decided to issue its third private, unsecured convertible bond. Part of the proceeds will be used to repay debt; the remaining use is not specified in the available text.
M impact | EQUITY | Nov 04, 2026, 08:42 AM UTC
Proteina to issue private convertible bonds
Proteina decided to issue privately placed, bearer, unsecured convertible bonds.
M impact | EQUITY | Nov 04, 2026, 08:42 AM UTC
Lunit to Issue KRW 47.7 Billion in Convertible Bonds
L impact | EQUITY | Nov 04, 2026, 08:42 AM UTC